Mersana Therapeutics Revenue 2016-2018 | MRSN

Current and historical revenue for Mersana Therapeutics (MRSN) from 2016 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Mersana Therapeutics revenue for the twelve months ending March 31, 2018 was $0.016B. Mersana Therapeutics revenue for the three months ending March 31, 2018 was $0.003B, representing a 28.58% decline from the same quarter last year.
Mersana Therapeutics Annual Revenue
(Millions of US $)
2017 $18
2016 $25
2015 $10
Mersana Therapeutics Quarterly Revenue
(Millions of US $)
Q1 2018 $3
Q4 2017 $3
Q3 2017 $6
Q2 2017 $4
Q1 2017 $4
Q4 2016 $0
Q3 2016 $3
Q2 2016 $6
Q4 2015 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.295B $0.018B
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.843B 14.44
Gilead Sciences (GILD) United States $99.468B 11.04
Biogen (BIIB) United States $69.095B 14.65
Celgene (CELG) United States $64.154B 12.81
Illumina (ILMN) United States $48.547B 60.82
Vertex Pharmaceuticals (VRTX) United States $44.677B 101.64
Regeneron Pharmaceuticals (REGN) United States $39.849B 22.41
Alexion Pharmaceuticals (ALXN) United States $26.493B 19.91
BioMarin Pharmaceutical (BMRN) United States $18.018B 0.00
Incyte (INCY) United States $13.698B 460.29
Seattle Genetics (SGEN) United States $11.644B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.803B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.361B 60.17
BeiGene (BGNE) Cayman Islands $8.886B 0.00
QIAGEN (QGEN) Netherlands $8.737B 28.57
Sarepta Therapeutics (SRPT) United States $8.606B 0.00
Bluebird Bio (BLUE) United States $8.568B 0.00
Alkermes (ALKS) Ireland $6.839B 0.00
Bio-Techne Corp (TECH) United States $6.714B 45.12
Exact Sciences (EXAS) United States $6.129B 0.00
Exelixis (EXEL) United States $6.080B 19.81
Galapagos (GLPG) Belgium $5.547B 0.00
Ligand Pharmaceuticals (LGND) United States $5.115B 45.31
Immunomedics (IMMU) United States $3.951B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.861B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.824B 0.00
Horizon Pharma Public (HZNP) Ireland $3.491B 19.76
Intercept Pharmaceuticals (ICPT) United States $3.356B 0.00
Array BioPharma (ARRY) United States $3.117B 0.00
China Biologic Products (CBPO) China $3.093B 20.43
Blueprint Medicines (BPMC) United States $3.022B 0.00
Myriad Genetics (MYGN) United States $3.013B 36.04
Akcea Therapeutics (AKCA) United States $2.994B 0.00
Amicus Therapeutics (FOLD) United States $2.903B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.887B 0.00
Medicines (MDCO) United States $2.843B 0.00
Ascendis Pharma (ASND) Denmark $2.807B 0.00
Emergent Biosolutions (EBS) United States $2.753B 21.92
Halozyme Therapeutics (HALO) United States $2.452B 32.67
Global Blood Therapeutics (GBT) United States $2.402B 0.00
MyoKardia (MYOK) United States $2.399B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.242B 0.00
Spark Therapeutics (ONCE) United States $2.195B 0.00
Acceleron Pharma (XLRN) United States $2.185B 0.00
REGENXBIO (RGNX) United States $2.178B 34.21
Repligen (RGEN) United States $2.158B 72.46
Cambrex (CBM) United States $2.042B 16.37
Momenta Pharmaceuticals (MNTA) United States $2.034B 0.00
AnaptysBio (ANAB) United States $2.006B 0.00
Genomic Health (GHDX) United States $1.945B 108.50
G1 THERAPEUTICS (GTHX) United States $1.894B 0.00
Mirati Therapeutics (MRTX) United States $1.893B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.865B 0.00
Rubius Therapeutics (RUBY) United States $1.837B 0.00
Clovis Oncology (CLVS) United States $1.831B 0.00
Arena Pharmaceuticals (ARNA) United States $1.811B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.768B 0.00
Atara Biotherapeutics (ATRA) United States $1.728B 0.00
Insmed (INSM) United States $1.712B 0.00
Puma Biotechnology (PBYI) United States $1.700B 0.00
Reata Pharmaceuticals (RETA) United States $1.681B 0.00
Aimmune Therapeutics (AIMT) United States $1.660B 0.00
Sangamo Therapeutics (SGMO) United States $1.591B 0.00
Allakos (ALLK) United States $1.575B 0.00
Myovant Sciences (MYOV) United Kingdom $1.454B 0.00
IMMURON LTD (IMRN) Australia $1.452B 0.00
Denali Therapeutics (DNLI) United States $1.430B 0.00
Innoviva (INVA) United States $1.414B 9.08
Editas Medicine (EDIT) United States $1.413B 0.00
Lion Biotechnologies (IOVA) United States $1.400B 0.00
Solid Biosciences (SLDB) United States $1.351B 0.00
Audentes Therapeutics (BOLD) United States $1.345B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.340B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.314B 0.00
UniQure (QURE) Netherlands $1.311B 0.00
BIOHAVEN PHARM (BHVN) United States $1.308B 0.00
WAVE Life Sciences (WVE) Singapore $1.290B 0.00
Coherus BioSciences (CHRS) United States $1.289B 0.00
Acorda Therapeutics (ACOR) United States $1.277B 26.63
Intellia Therapeutics (NTLA) United States $1.195B 0.00
Cellectis (CLLS) France $1.171B 0.00
Athenex (ATNX) United States $1.169B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.164B 0.00
Intra-Cellular Therapies (ITCI) United States $1.161B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.134B 2165.00
Zai Lab Unsponsored ADR (ZLAB) China $1.112B 0.00
CytomX Therapeutics (CTMX) United States $1.094B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.082B 0.00
Retrophin (RTRX) United States $1.048B 0.00
DBV Technologies (DBVT) France $1.048B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.043B 0.00
Apellis Pharmaceuticals (APLS) United States $1.038B 0.00
NeoGenomics (NEO) United States $1.020B 178.57
AVROBIO (AVRO) United States $0.981B 0.00
Revance Therapeutics (RVNC) United States $0.979B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.884B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.864B 0.00
Amarin (AMRN) Ireland $0.836B 0.00
Dynavax Technologies (DVAX) United States $0.833B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.827B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.773B 0.00
Cara Therapeutics (CARA) United States $0.768B 0.00
Heska (HSKA) United States $0.734B 63.16
NuCana Sponsored ADR (NCNA) United Kingdom $0.732B 0.00
InflaRx (IFRX) Germany $0.727B 0.00
Kura Oncology (KURA) United States $0.725B 0.00
Aptinyx (APTX) United States $0.714B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.699B 0.00
Epizyme (EPZM) United States $0.697B 0.00
Geron (GERN) United States $0.692B 0.00
ANI Pharmaceuticals (ANIP) United States $0.673B 13.36
UNITY Biotechnology (UBX) $0.666B 0.00
Abeona Therapeutics (ABEO) United States $0.646B 0.00
UROGEN PHARMA (URGN) Israel $0.645B 0.00
Sorrento Therapeutics (SRNE) United States $0.630B 0.00
Viking Therapeutics (VKTX) United States $0.628B 0.00
AC Immune SA (ACIU) Switzerland $0.618B 0.00
Fate Therapeutics (FATE) United States $0.614B 0.00
Eidos Therapeutics (EIDX) United States $0.605B 0.00
Anika Therapeutics (ANIK) United States $0.604B 25.40
Verastem (VSTM) United States $0.599B 0.00
Prothena (PRTA) Ireland $0.597B 0.00
Mesoblast (MESO) Australia $0.593B 0.00
Vericel (VCEL) United States $0.551B 0.00
Novavax (NVAX) United States $0.547B 0.00
ObsEva SA (OBSV) Switzerland $0.547B 0.00
BeyondSpring (BYSI) United States $0.529B 0.00
Arcus Biosciences (RCUS) United States $0.526B 0.00
Arbutus Biopharma (ABUS) Canada $0.524B 0.00
Replimune (REPL) United States $0.521B 0.00
Kindred Biosciences (KIN) United States $0.507B 0.00
Senesco Technologies (ELOX) United States $0.501B 0.00
Five Prime Therapeutics (FPRX) United States $0.501B 0.00
MiMedx (MDXG) United States $0.476B 20.43
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.472B 0.00
Unum Therapeutics (UMRX) United States $0.469B 0.00
Zymeworks (ZYME) Canada $0.453B 0.00
Stemline Therapeutics (STML) United States $0.453B 0.00
Aduro Biotech (ADRO) United States $0.447B 0.00
Magenta Therapeutics (MGTA) United States $0.428B 0.00
Merus (MRUS) Netherlands $0.426B 0.00
Zealand Pharma (ZEAL) Denmark $0.423B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.420B 0.00
Evelo Biosciences (EVLO) United States $0.417B 0.00
Syros Pharmaceuticals (SYRS) United States $0.411B 0.00
Inovio Pharmaceuticals (INO) United States $0.408B 0.00
GTx (GTXI) United States $0.403B 0.00
Vital Therapies (VTL) United States $0.398B 0.00
MediciNova (MNOV) United States $0.395B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.395B 0.00
Sinovac Biotech (SVA) China $0.391B 0.00
Cytokineticsorporated (CYTK) United States $0.382B 0.00
Albireo Pharma (ALBO) United States $0.373B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.370B 0.00
Scholar Rock Holding (SRRK) United States $0.363B 0.00
RA PHARMCTL INC (RARX) United States $0.352B 0.00
PDL BioPharma (PDLI) United States $0.348B 4.88
Cellular Biomedicine (CBMG) United States $0.345B 0.00
Adverum Biotechnologies (ADVM) United States $0.329B 0.00
Seres Therapeutics (MCRB) United States $0.324B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.320B 0.00
Kezar Life Sciences (KZR) United States $0.319B 0.00
ResTORbio (TORC) United States $0.317B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.317B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.312B 0.00
Kala Pharmaceuticals (KALA) United States $0.310B 0.00
Selecta Biosciences (SELB) United States $0.308B 0.00
Osiris Therapeutics (OSIR) United States $0.307B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.307B 0.00
BioTime (BTX) United States $0.297B 0.00
Celyad SA (CYAD) Belgium $0.291B 0.00
Cohbar (CWBR) United States $0.290B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.290B 0.00
Athersys (ATHX) United States $0.285B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.285B 0.00
Strongbridge Biopharma (SBBP) United States $0.285B 0.00
ADMA Biologics Inc (ADMA) United States $0.280B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.274B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.273B 0.00
Kadmon Holdings (KDMN) United States $0.268B 0.00
Constellation Pharmaceuticals (CNST) United States $0.266B 0.00
Celcuity (CELC) United States $0.253B 0.00
Axovant Sciences (AXON) United Kingdom $0.253B 0.00
NantKwest (NK) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.249B 0.00
Clearside Biomedical (CLSD) United States $0.243B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.240B 0.00
MeiraGTx Holdings (MGTX) United States $0.238B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.234B 0.00
Allena Pharmaceuticals (ALNA) United States $0.224B 0.00
Protagonist Therapeutics (PTGX) United States $0.221B 0.00
Kamada (KMDA) Israel $0.209B 16.25
Aeglea BioTherapeutics (AGLE) United States $0.209B 0.00
Agenus (AGEN) United States $0.205B 0.00
Spero Therapeutics (SPRO) United States $0.205B 0.00
Liquidia Technologies (LQDA) United States $0.198B 0.00
Synlogic (SYBX) United States $0.196B 0.00
Enzo Biochem (ENZ) United States $0.195B 0.00
Palatin Technologies (PTN) United States $0.184B 7.12
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.182B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.182B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
TOCAGEN INC (TOCA) United States $0.181B 0.00
MannKind (MNKD) United States $0.181B 0.00
Signal Genetics (MGEN) United States $0.180B 0.00
Mustang Bio (MBIO) United States $0.174B 0.00
BioDelivery Sciences (BDSI) United States $0.171B 0.00
Idera Pharmaceuticals (IDRA) United States $0.170B 0.00
Cue Biopharma (CUE) United States $0.167B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.167B 0.00
Krystal Biotech (KRYS) United States $0.166B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.164B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.159B 0.00
Compugen (CGEN) Israel $0.156B 0.00
XOMA (XOMA) United States $0.155B 16.31
OVID THERAPEUTC (OVID) United States $0.152B 0.00
Cerecor (CERC) United States $0.151B 18.58
XBiotech (XBIT) United States $0.149B 0.00
BioXcel Therapeutics (BTAI) United States $0.145B 0.00
Monster Digital (INNT) United States $0.140B 0.00
Pluristem Therapeutics (PSTI) Israel $0.139B 0.00
Intec Pharma (NTEC) Israel $0.130B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.126B 0.00
Anavex Life Sciences (AVXL) United States $0.124B 0.00
Trevena (TRVN) United States $0.124B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.120B 0.00
Motif Bio Plc (MTFB) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.120B 0.00
PSivida (EYPT) United States $0.119B 0.00
Provention Bio (PRVB) United States $0.119B 0.00
Pfenex (PFNX) United States $0.116B 0.00
Cocrystal Pharma (COCP) United States $0.112B 0.00
NewLink Genetics (NLNK) United States $0.112B 0.00
Fortress Biotech (FBIO) United States $0.111B 0.00
Aptevo Therapeutics (APVO) United States $0.109B 0.00
Leap Therapeutics (LPTX) United States $0.106B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.102B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.101B 0.00
Aptose Biosciences (APTO) Canada $0.101B 0.00
Orgenesis (ORGS) United States $0.101B 0.00
Asterias Biotherapeutics (AST) United States $0.097B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.093B 0.00
Ophthotech (OPHT) United States $0.088B 0.57
Proteostasis Therapeutics (PTI) United States $0.088B 0.00
Eleven Biotherapeutics (SESN) United States $0.087B 0.00
ScPharmaceuticals (SCPH) United States $0.085B 0.00
Alcobra (ARCT) Israel $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.085B 0.00
Sophiris Bio (SPHS) United States $0.083B 0.00
Tapimmune (TPIV) United States $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.081B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
OncoSec Medical (ONCS) United States $0.079B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Evogene (EVGN) Israel $0.073B 0.00
Protalix BioTherapeutics (PLX) Israel $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Histogenics (HSGX) United States $0.070B 0.00
VIVUS (VVUS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Axsome Therapeutics (AXSM) United States $0.064B 0.00
Novelion Therapeutics (NVLN) Canada $0.062B 0.00
Entera Bio (ENTX) Israel $0.062B 0.00
Eyenovia (EYEN) United States $0.055B 0.00
Neothetics (EVFM) United States $0.055B 0.00
Curis (CRIS) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.051B 0.00
VolitionRX (VNRX) Singapore $0.051B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Celsion (CLSN) United States $0.048B 0.00
CorMedix Inc (CRMD) United States $0.048B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Chiasma (CHMA) United States $0.043B 0.00
Proteon Therapeutics (PRTO) United States $0.041B 0.00
GENPREX INC (GNPX) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
TRACON Pharmaceuticals (TCON) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
CytRx (CYTR) United States $0.038B 0.00
Bellerophon Therapeutics (BLPH) United States $0.036B 0.00
Aileron Therapeutics (ALRN) United States $0.036B 0.00
BioPharmX (BPMX) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.033B 0.00
Arsanis (ASNS) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.032B 64.67
Benitec Biopharma (BNTC) Australia $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
OvaScience (OVAS) United States $0.029B 0.00
Vical (VICL) United States $0.029B 0.00
Edge Therapeutics (EDGE) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Oncobiologics (ONS) United States $0.027B 0.00
Gemphire Therapeutics (GEMP) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Adial Pharmaceuticals (ADIL) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.020B 0.00
Cel-Sci (CVM) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Neuralstem (CUR) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
RestorGenex (DFFN) United States $0.018B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Synthetic Biologics (SYN) United States $0.015B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.41
Cerulean Pharma (DARE) United States $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
IBio (IBIO) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Galena Biopharma (SLS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Oragenics (OGEN) United States $0.003B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00